# reload+after+2024-01-20 07:46:16.921972
address1§Building B
address2§11 HaMenofim Street
city§Herzliya
zip§4672562
country§Israel
phone§972 9 799 6183
website§https://www.neurosense-tx.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases in the United States and internationally. Its lead product is PrimeC, an extended-release oral formulation of a fixed dose combination of ciprofloxacin and celecoxib for the treatment of amyotrophic lateral sclerosis. The company's preclinical pipeline includes StabiliC for the treatment of Parkinson's disease; and CogniC for the treatment of Alzheimer's disease. NeuroSense Therapeutics Ltd. was incorporated in 2017 and is headquartered in Herzliya, Israel.
fullTimeEmployees§14
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Alon  Ben-Noon', 'age': 44, 'title': 'Co-Founder, CEO & Director', 'yearBorn': 1979, 'fiscalYear': 2022, 'totalPay': 619000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Or  Eisenberg', 'age': 42, 'title': 'Chief Financial Officer', 'yearBorn': 1981, 'fiscalYear': 2022, 'totalPay': 378000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Ferenc  Tracik M.D.', 'age': 59, 'title': 'Chief Medical Officer', 'yearBorn': 1964, 'fiscalYear': 2022, 'totalPay': 513000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Hagit  Binder', 'age': 45, 'title': 'Chief Operation Officer', 'yearBorn': 1978, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Niva  Russek-Blum Ph.D.', 'age': 44, 'title': 'Chief Technology Officer', 'yearBorn': 1979, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Yael  Barak', 'age': 53, 'title': 'VP of Quality & Compliance', 'yearBorn': 1970, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Keren  Pushett', 'title': 'Head of HR', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Eidan  Loushi', 'title': 'C.R.A.', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
beta§1.331
currency§USD
exchange§NCM
quoteType§EQUITY
shortName§NEUROSENSE THERAPEUTICS LTD C/W
longName§NeuroSense Therapeutics Ltd.
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§49cbd2ba-b060-349a-9719-db9d2d7cec17
gmtOffSetMilliseconds§-18000000
recommendationKey§none
quickRatio§1.804
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
